University Of Cincinnati

This study tested two immunotherapy drugs, durvalumab and tremelimumab, in 8 people with liver cancer who were waiting for a liver transplant. The goal was to see if the drugs could safely shrink tumors and control the disease without causing organ rejection. The trial was stoppe…